Pharmaceuticals Companies By Operating Margin

Operating Margin
Operating MarginEfficiencyMarket RiskExp Return
1ARVN Arvinas
3.84
(0.09)
 3.12 
(0.27)
2RPRX Royalty PharmaPlc
1.03
(0.01)
 1.74 
(0.03)
3SIGA SIGA Technologies
0.79
 0.25 
 4.35 
 1.09 
4INVA Innoviva
0.53
(0.12)
 1.14 
(0.14)
5NVO Novo Nordisk AS
0.43
 0.13 
 2.01 
 0.27 
6COLL Collegium Pharmaceutical
0.41
 0.06 
 2.34 
 0.14 
7LLY Eli Lilly and
0.34
 0.13 
 1.70 
 0.22 
8ZTS Zoetis Inc
0.32
(0.14)
 2.03 
(0.29)
9NVS Novartis AG ADR
0.31
(0.06)
 1.14 
(0.07)
10PBH Prestige Brand Holdings
0.31
 0.11 
 1.62 
 0.18 
11AMPH Amphastar P
0.3
(0.17)
 2.56 
(0.44)
12JNJ Johnson Johnson
0.29
(0.16)
 0.81 
(0.13)
13TEVA Teva Pharma Industries
0.28
 0.15 
 1.79 
 0.26 
14RDY Dr Reddys Laboratories
0.25
 0.09 
 1.21 
 0.11 
15HRMY Harmony Biosciences Holdings
0.24
(0.04)
 2.68 
(0.12)
16CORT Corcept Therapeutics Incorporated
0.23
 0.01 
 2.69 
 0.03 
17JAZZ Jazz Pharmaceuticals PLC
0.23
(0.15)
 1.70 
(0.26)
18BHC Bausch Health Companies
0.21
 0.04 
 2.46 
 0.10 
19GSK GlaxoSmithKline PLC ADR
0.2
 0.10 
 1.00 
 0.10 
20OGN Organon Co
0.2
 0.07 
 2.66 
 0.18 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations. A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.